Our passion is to expedite novel cellular immunotherapy from lab to bedside
Overnight production, lowcost, high potency, andsafe profile
Simultaneously target 2 antigens Improved safety profile
Selected genes edited to avoid GvHD and rejection without use of strong immune suppressive drug
Learn more about Gracell in real time, industry news courier.